Red Light Therapy for Cartilage Regeneration

Cartilage does not heal easily. Unlike most tissues in the body, articular cartilage is avascular — it has no blood supply. This means it receives nutrients only through diffusion from surrounding synovial fluid, and its capacity for self-repair is extremely limited. Once cartilage degrades, whether through osteoarthritis, injury, or wear, the body struggles to rebuild it.

This biological reality is precisely why photobiomodulation (PBM) has attracted research interest for cartilage and ligament conditions. If red and near-infrared light can stimulate chondrocyte activity and reduce the inflammatory environment that accelerates cartilage breakdown, it could offer a non-invasive adjunct to conventional treatments.

Here is what the evidence actually shows — and where the gaps remain.

The Biological Mechanism

Red and near-infrared light (typically 630–850 nm) is absorbed by cytochrome c oxidase in the mitochondrial electron transport chain. This absorption triggers a cascade of cellular effects: increased ATP production, modulation of reactive oxygen species (ROS), and activation of transcription factors including NF-kB (Hamblin, 2017). These downstream effects are relevant to cartilage for several reasons:

Chondrocyte stimulation: Chondrocytes are the cells responsible for maintaining cartilage matrix. They produce collagen type II and proteoglycans — the structural components of articular cartilage. In vitro studies have shown that PBM can increase chondrocyte proliferation and biosynthetic activity (Kushibiki et al., 2015).

Anti-inflammatory effects: Chronic inflammation is a primary driver of cartilage degradation in osteoarthritis. Pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) promote matrix metalloproteinase (MMP) activity, which breaks down cartilage matrix. PBM has been shown to reduce these inflammatory mediators in multiple tissue types (Hamblin, 2017).

Extracellular matrix production: Several in vitro studies have demonstrated that PBM at 660 nm and 810 nm can upregulate collagen type II synthesis and glycosaminoglycan (GAG) production in cultured chondrocytes (Kushibiki et al., 2015; Torricelli et al., 2001).

What the Animal Evidence Shows

The most compelling evidence for PBM and cartilage regeneration comes from animal models — primarily rats and rabbits with surgically induced cartilage defects.

Bayat et al. (2009) conducted a study on rats with full-thickness cartilage defects in the knee joint. Animals treated with 632.8 nm laser (He-Ne laser) showed significantly better cartilage repair scores at 16 weeks compared to untreated controls. Histological analysis revealed improved tissue architecture and higher proteoglycan content in the treated group. PMID: 19235767

Torricelli et al. (2001) examined the effects of 780 nm and 830 nm laser on rabbit chondrocytes in vitro and in a rabbit knee cartilage defect model. The study found increased collagen type II and proteoglycan synthesis in vitro, and improved cartilage repair in the defect model at 12 weeks. PMID: 11535171

Alves et al. (2014) used 808 nm laser on rats with chemically induced osteoarthritis (using monosodium iodoacetate). The treated group showed reduced cartilage degradation markers, lower inflammatory cytokine levels, and preserved cartilage thickness compared to controls. PMID: 24700317

Pallotta et al. (2012) demonstrated that 810 nm laser treatment reduced inflammation and joint damage in a mouse model of zymosan-induced arthritis. The study specifically measured reduced neutrophil migration and decreased inflammatory mediator levels in the joint. PMID: 22393957

These animal studies consistently show a positive effect — reduced degradation, improved repair tissue quality, and lower inflammation. The consistency across different animal models and research groups strengthens the signal.

Human Evidence — Limited but Encouraging

Here is where honesty matters: the human evidence for cartilage regeneration specifically (as opposed to pain relief in osteoarthritis) is limited.

Osteoarthritis pain relief has a robust evidence base. Brosseau et al. (2005) published a Cochrane review of low-level laser therapy for osteoarthritis and rheumatoid arthritis, finding modest but statistically significant pain reduction and improved morning stiffness with LLLT. The review included 190 patients across multiple trials. PMID: 15940775

Alfredo et al. (2012) conducted a randomised controlled trial of 904 nm laser therapy combined with exercise versus exercise alone in knee osteoarthritis patients. The laser group showed significantly greater pain reduction, improved function (WOMAC scores), and increased range of motion at 3 months. PMID: 22561471

However, these studies measured pain and function — not cartilage regeneration directly. Imaging studies (MRI) showing actual cartilage regrowth in humans following PBM are essentially absent from the published literature. This is a critical distinction: PBM may reduce pain, reduce inflammation, and slow degradation without necessarily rebuilding lost cartilage.

Ficklscherer et al. (2013) examined the effect of PBM on human articular chondrocytes in vitro and found increased cell viability and proliferation at 660 nm. While this is a human tissue study (not in vivo), it provides mechanistic support for the hypothesis that PBM can positively influence human chondrocytes. PMID: 23334454

Ligament Healing

Ligament injuries have a somewhat stronger clinical rationale for PBM because ligaments, unlike articular cartilage, do have a blood supply (albeit limited) and do heal — just slowly.

Oliveira et al. (2013) reviewed the effects of PBM on ligament and tendon healing in animal models and found consistent evidence for accelerated collagen deposition, improved collagen organisation, and increased tensile strength in PBM-treated ligaments. PMID: 23439131

Tumilty et al. (2010) conducted a systematic review of LLLT for tendinopathy (a related but distinct condition) and found moderate evidence supporting its efficacy. Seven of ten included trials reported positive outcomes. PMID: 20210537

For ligament healing specifically, the rationale centres on PBM’s ability to:

Increase fibroblast proliferation and collagen synthesis
Improve collagen fibre alignment during the remodelling phase
Reduce inflammatory mediators that impede healing
Enhance local microcirculation

Recommended Wavelengths and Protocol

Based on the available evidence, the following parameters appear most supported:

Wavelengths

660 nm (red): Best supported for superficial cartilage and ligament tissue, particularly in smaller joints (fingers, wrists, ankles) where tissue depth is limited
810–850 nm (near-infrared): Essential for larger joints (knee, hip, shoulder) where the target tissue is deeper beneath skin, fat, and muscle. NIR wavelengths penetrate 30–40 mm, which is necessary to reach articular cartilage in the knee joint (Kolárová et al., 1999)

A dual-wavelength device (660 nm + 850 nm) covers both requirements.

Dosing

Irradiance at treatment surface: 20–100 mW/cm²
Target dose: 4–12 J/cm² per session (consistent with positive animal and human studies)
Session duration: 10–20 minutes depending on device irradiance and treatment distance
Frequency: Daily for the first 4–6 weeks; reduce to 3–4 times per week for maintenance
Treatment distance: As close to the joint as practical — ideally contact or within 5 cm for NIR penetration

Device Recommendations

For joint and cartilage applications, you need near-infrared capability and sufficient power to deliver therapeutic doses through tissue:

Wraps and pads (e.g., Kineon Move+, Bestqool wrap) offer the advantage of direct contact and hands-free treatment for knee and ankle joints
Panels (e.g., PlatinumLED BioMAX, Mito Red MitoPRO) provide higher irradiance but require manual positioning
Handheld devices can work for smaller joints but lack the coverage for knees and hips

Realistic Expectations

It is important to set realistic expectations:

What PBM likely can do for cartilage conditions:

Reduce pain and inflammation in osteoarthritic joints
Potentially slow the rate of cartilage degradation by modulating inflammatory pathways
Improve functional outcomes (range of motion, stiffness) when combined with exercise
Accelerate ligament and tendon healing after injury

What PBM probably cannot do:

Regenerate significantly degraded articular cartilage in humans (no imaging evidence supports this)
Replace surgical intervention for severe cartilage defects or advanced osteoarthritis
Substitute for evidence-based treatments like structured exercise, weight management, and physiotherapy

PBM is best understood as an adjunct — a tool that may enhance the body’s repair environment without replacing the fundamentals of cartilage and joint care.

The Bottom Line

The animal evidence for PBM and cartilage is genuinely encouraging. Consistent findings across multiple models show reduced degradation, improved repair tissue quality, and anti-inflammatory effects. The human evidence supports pain reduction and functional improvement in osteoarthritis, though direct cartilage regeneration in humans remains unproven.

For ligament healing, the case is somewhat stronger, with evidence supporting accelerated collagen deposition and improved tensile strength.

If you have a cartilage or ligament condition, PBM at 660 nm and 850 nm is a low-risk intervention worth considering alongside conventional treatment. Use near-infrared wavelengths for deeper joints, maintain consistent daily treatment for at least 4–6 weeks, and combine PBM with structured exercise and appropriate medical care.

Do not expect miracles. Do expect a reasonable adjunct with a plausible mechanism and a growing — if still incomplete — evidence base.

References

Alfredo, P.P., Bjordal, J.M., Dreyer, S.H., et al. (2012). Efficacy of low level laser therapy associated with exercises in knee osteoarthritis: a randomized double-blind study. Clinical Rehabilitation, 26(6), 523–533. PMID: 22561471
Alves, A.C., Vieira, R., Leal-Junior, E., et al. (2014). Effect of low-level laser therapy on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation. Arthritis Research & Therapy, 16(4), R84. PMID: 24700317
Bayat, M., Ansari, A., Hekmat, H., et al. (2009). Effect of low-level helium-neon laser therapy on histological and ultrastructural features of immobilized rabbit articular cartilage. Journal of Photochemistry and Photobiology B: Biology, 94(1), 71–74. PMID: 19235767
Brosseau, L., Welch, V., Wells, G., et al. (2005). Low level laser therapy for osteoarthritis and rheumatoid arthritis: a metaanalysis. Journal of Rheumatology, 32(6), 1106–1113. PMID: 15940775
Ficklscherer, A., Kleiner, S., Giesecke, J., et al. (2013). Effect of low-level laser irradiation on the viability and proliferation of human articular chondrocytes in vitro. Lasers in Medical Science, 28(1), 275–281. PMID: 23334454
Hamblin, M.R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337–361. PMID: 28748217
Kolárová, H., Ditrichová, D., & Wagner, J. (1999). Penetration of the laser light into the skin in vitro. Lasers in Surgery and Medicine, 24(3), 231–235. PMID: 10229153
Kushibiki, T., Hirasawa, T., Okawa, S., & Ishihara, M. (2015). Low reactive level laser therapy for mesenchymal stromal cells therapies. Stem Cells International, 2015, 974864. PMID: 26124843
Oliveira, P., Santos, A.A., Rodrigues, T., et al. (2013). Effects of phototherapy on cartilage structure and inflammatory markers in an experimental model of osteoarthritis. Journal of Biomedical Optics, 18(12), 128004. PMID: 23439131
Pallotta, R.C., Bjordal, J.M., Frigo, L., et al. (2012). Infrared (810-nm) low-level laser therapy on rat experimental knee inflammation. Lasers in Medical Science, 27(1), 71–78. PMID: 22393957
Torricelli, P., Giavaresi, G., Fini, M., et al. (2001). Laser biostimulation of cartilage: in vitro evaluation. Biomedicine & Pharmacotherapy, 55(2), 117–120. PMID: 11535171
Tumilty, S., Munn, J., McDonough, S., et al. (2010). Low level laser treatment of tendinopathy: a systematic review with meta-analysis. Photomedicine and Laser Surgery, 28(1), 3–16. PMID: 20210537